US Futures turn higher, watch LOW, TGT, MRNA, JNJ, URBN

The S&P 500 Futures are rebounding after they closed in the red yesterday, halting a three-session rally.


The S&P 500 Futures are rebounding after they closed in the red yesterday, halting a three-session rally.

In the afternoon will be released the minutes from the last FOMC meeting

European indices are searching for a trend. The European Commission has posted final readings of April CPI at +0.3% (vs +0.4% on year expected). The U.K. Office for National Statistics has released April CPI at +0.8% (+0.9% on year expected) and April PPI at -0.7%, vs -0.5% expected.

Asian indices closed in a mixed mood. Japanese Nikkei, Australian ASX and Hong Kong HSI closed on the upside whereas Chinese CSI closed in the red. Japan's core machinery orders slid 0.4% on month in March (-6.7% expected). Australia's preliminary retail sales dropped 17.9% on month in April (+8.5% in March).

WTI Crude Oil Futures remain on the upside. The American Petroleum Institute (API) reported that U.S. crude oil stockpile fell 4.8 million barrels for week ended May 15. Later today, EIA will release crude oil inventories data for last week.

Gold rose 5.05 dollars (+0.29%) to 1750.1 dollars, still firm on weak global economic outlook.

The EUR/USD gained 18pips to 1.0941, still well oriented following the EU common fund proposal.

US Equity Snapshot

Lowe's (LOW), the second-largest home improvement retailer in the US, surged before hours after reporting first quarter adjusted EPS up 45% to 1.77 dollar. Comparable sales jumped 11.2%. Both figures beat estimates. Also, the company withdraws full year financial guidance.

Target (TGT), the retailer, unveiled first quarter comparable sales up 10.8% vs a 4.8% increase for the same period of last year. Digital sales jumped but the company saw also an increase in labor expenses and fewer sales of high-margin items.

Moderna (MRNA) lost ground in extended trading after STAT reported that vaccine experts say the biotech "didn’t produce data critical to assessing Covid-19 vaccine".

Johnson & Johnson (JNJ), the healthcare giant, announced the discontinuation of talc-based Johnson’s Baby Powder in U.S. and Canada.

Urban Outfitters (URBN), the clothing retailer, posted first quarter loss of 138.4 million dollars, or 1.41 dollar a share, vs a net income of 32.6 million dollars, or 0.31 dollar a share, a year earlier. Sales fell to 588.5 million dollars from 864.4 million dollars a year ago. Those figures missed estimates. The company warned second quarter comparable sales could decrease more than 60%.

Source : TradingVIEW, Gain Capital

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.